FDA Approves FOCINVEZ — Steriscience Specialties Private Limited

# FDA Approves Steriscience Specialties' FOCINVEZ, Expanding IV Antiemetic Options in Competitive Market Steriscience Specialties Private Limited received FDA approval for FOCINVEZ (fosaprepitant dimeglumine), an intravenous formulation of the NK1 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting, marking another entry in the competitive antiemetic market dominated by established players like Helsinn and Teva. The intravenous route approval may provide healthcare providers with additional flexibility in treatment